YC CONSULTING, LLC

Lobbying for GENENTECH, INC. · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $50,000.00 income · posted Apr 20, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

Issues related to drug pricing and patient access

H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.